📌 Key Takeaways
- The Fem Medical Association , founded April 8, 2025,
is Japan’s first physician-led body dedicated to cross-specialty femtech medicine. - The Fem Medical Symposium 2026 takes place November 15, 2026
at THE GRAND GINZA (GINZA SIX 13F, Tokyo) —
physicians only, 60 in-person seats, ¥5,000 entry, with live online streaming. - The event bridges OB-GYN, female urology, and aesthetic medicine
around vaginal/pelvic floor treatment, regenerative medicine,
and gynecological cosmetic surgery. - Founding representative Dr. Akiko Miyamoto leads a board
that includes specialists from multiple clinical disciplines,
signaling a structural shift in how Japan organizes femtech medical education.
The word “femtech” has gone mainstream.
From menstrual products and fertility apps to pelvic floor rehabilitation
and vaginal regenerative medicine, the market has expanded rapidly.
But market growth does not automatically guarantee clinical quality.
The vaginal, pelvic floor, and gynecological aesthetics space
sits at the intersection of obstetrics-gynecology, female urology,
and aesthetic medicine — three specialties with distinct training backgrounds,
evidence standards, and institutional cultures.
In 2025, a group of Japanese physicians decided to do something about that.
What Is the Fem Medical Association — and Why Now?
The Fem Medical Association (フェムメディカル協会) was formally established
on April 8, 2025, headquartered in Ebisu, Shibuya, Tokyo.
Its founding mission, as stated on the association’s official website, is:
“Established with the purpose of creating a world in which all women
can face themselves and make choices based on accurate knowledge.
Through accurate communication and activities by specialist physicians
well-versed in women’s minds and bodies — including OB-GYN, urology,
and internal medicine — we aim to realize safe femtech medicine.”
The association identifies three structural problems driving its creation
(per official press release):
performed without sufficient anatomical expertise.
with the rapid expansion of out-of-pocket (non-covered) aesthetic procedures.
female urology, and aesthetic medicine practitioners.
In Japan, many aesthetic procedures — including vaginal laser treatments,
pelvic floor fillers, and labiaplasty — are offered as jiyū-shinryō
(out-of-pocket, non-insurance-covered care).
This creates a regulatory gray zone where clinical standards
are not uniformly enforced across specialties.
The Fem Medical Association’s effort mirrors similar cross-specialty
standardization movements seen in Europe and North America
around pelvic floor medicine and vaginal rejuvenation.Pelvic floor medicine refers to the clinical management of the network
of muscles, nerves, and ligaments forming the base of the pelvis.
Dysfunction — often linked to childbirth or aging — can cause
pelvic organ prolapse, urinary incontinence, and sexual dysfunction.
It sits at the intersection of OB-GYN and urology,
making cross-specialty collaboration structurally necessary.
Fem Medical Symposium 2026: Event Details
The association’s first large-scale academic symposium
is scheduled for November 15, 2026, in Tokyo’s Ginza district.
Registration is open via Peatix. The following details were confirmed directly.
Networking reception: 16:00–17:30
(6-10-1 Ginza, Chuo-ku, Tokyo)
The symposium’s stated concept (confirmed via Peatix event page):
“Learning femtech medicine from board-certified OB-GYN
and urological specialists.
Topics spanning vaginal and pelvic floor medicine, regenerative medicine,
and gynecological cosmetic surgery —
crossing the boundary between gynecology and urology.”Note: Full speaker lineup and program schedule were not confirmed
at time of publication. Verify via Peatix or organizer materials.
Leadership and Organizational Structure
The association’s 2026 leadership structure, as publicly announced:
(BIANCA CLINIC / Nihonbashi Pelvic Floor Clinic)
· Dr. Ayako Nakamura (Women’s Medical Clinic LUNA)
· Dr. Ryozo Saito · Dr. Soka Nasu · Dr. Noriko Ninomiya
· Sakie Ladies Clinic · Women’s Clinic Urawa
Why This Movement Matters Beyond Japan
What is happening in Japan’s femtech medicine space
reflects a structural tension visible in aesthetic medicine globally.① Who is qualified to perform these procedures — and by whose standard?
Vaginal laser treatments, pelvic floor fillers, and labiaplasty
can legally be performed by OB-GYNs, urologists, plastic surgeons,
and aesthetic physicians alike in Japan.
“Performed by a specialist” does not automatically mean
“performed by the right specialist.”② Evidence is siloed by specialty society.
OB-GYN societies, urology societies, and aesthetic medicine bodies
may evaluate the same procedure using different evidence frameworks.
Without cross-specialty dialogue, standardization stalls.
③ Patients don’t know where to go.
A woman experiencing urinary leakage and vaginal laxity simultaneously
may not know whether to see a gynecologist, urologist, or aesthetic clinic.
Cross-specialty coordination could help build clearer patient referral pathways.
The Fem Medical Association’s model — physician-led, cross-specialty,
evidence-focused — mirrors efforts seen in Europe and North America
to formalize pelvic floor medicine as a distinct clinical discipline.
As “femtech” solidifies as a market category,
the clinical infrastructure around it remains a work in progress.
The Fem Medical Association’s initiative is notable precisely because
it represents physicians proactively building their own standardization framework —
rather than waiting for regulatory mandates.NERO will continue tracking cross-specialty developments
in women’s aesthetic and functional medicine as this field evolves.
- The Fem Medical Association was founded April 8, 2025,
with a mission to ensure all women can make informed choices
about their health based on accurate medical knowledge. - The Fem Medical Symposium 2026 takes place November 15, 2026,
13:00–16:00 at THE GRAND GINZA (GINZA SIX 13F, Tokyo).
Physicians only · 60 in-person seats · ¥5,000 · online streaming available.
Registration: femmedicalsymposium2026.peatix.com - The symposium focuses on vaginal and pelvic floor medicine,
regenerative medicine, and gynecological cosmetic surgery —
bridging OB-GYN and urology in a closed academic format for physicians. - Founding Representative Dr. Akiko Miyamoto leads a cross-specialty board.
Planned activities include biannual online academic conferences,
in-person technical training, cross-specialty referral network development,
and public education events.
dedicated to advancing safe femtech medicine through cross-specialty collaboration
among OB-GYN, urology, and aesthetic medicine specialists.
Its founding mission is to create a world where all women can make
informed health decisions based on accurate medical knowledge.
including those in OB-GYN, urology, and aesthetic medicine.
In-person capacity is limited to 60 attendees at THE GRAND GINZA, Tokyo.
Simultaneous online streaming is also available for registered participants.
fall within the scope of multiple specialties — OB-GYN, urology,
plastic surgery, and aesthetic medicine — each with different training
and evidence standards.
Without structured cross-specialty dialogue, clinical standardization
and patient referral pathways remain fragmented.
The Fem Medical Association aims to address this gap directly.
Sources:
1. Fem Medical Association Official Website. femmedicalassociation.studio.site (founding mission — directly verified)
2. Peatix. “Fem Medical Symposium 2026.” femmedicalsymposium2026.peatix.com (event details and concept — directly verified)
3. PR TIMES. “Fem Medical Association New Leadership Launch / Fem Medical Symposium 2026 Announcement.” prtimes.jp
